Choroidal thickness as a possible predictor of non-response to intravitreal bevacizumab for macular edema after retinal vein occlusion

To evaluate outcomes of intravitreal bevacizumab (IVB) treating macular edema (ME) after retinal vein occlusion (RVO) following pro re nata (PRN) regimen and investigate potential predictors of non-response. Retrospective analysis of 126 treatment-naive eyes with ME after RVO. Eyes were treated init...

Descripción completa

Detalles Bibliográficos
Autores principales: Aljundi, Wissam, Gradinger, Florian, Langenbucher, Achim, Sideroudi, Haris, Seitz, Berthold, Abdin, Alaa Din
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829912/
https://www.ncbi.nlm.nih.gov/pubmed/36624124
http://dx.doi.org/10.1038/s41598-023-27753-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829912/
https://www.ncbi.nlm.nih.gov/pubmed/36624124
http://dx.doi.org/10.1038/s41598-023-27753-7

Ejemplares similares